Skip to content

Public FDA record

Z-0262-2010: Intramedullary Skeletal Kinetic Distractor (ISKD) is an internal limb lengthening device consisting of a

Recall record Z-0262-2010 for Orthofix, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0262-2010
Company in FDA record
Orthofix, Inc
FDA classification date
Nov 13, 2009
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

ISKD lengthening device has the potential for not pre-distracting. This may cause or contribute to device malfunction, and if not discovered prior to use, may require surgical re-intervention or removal.

Source facts

Action
Firm notified consignees by letter sent via certified mail on 10/9/2009. Follow up is planned for nonresponders. Questions are directed to the firm at (800) 527-0404.
Initiated
2009-10-09
Root cause
Other
Terminated
2010-09-24
Distribution
Worldwide distribution - In the US: FL, MD, TN, OH, NY, CA, GA. Also Mexico, Italy, Canada.
Recall number
Z-0262-2010
Recall status
Terminated
CDRH record ID
85897
FDA classified
2009-11-13
Recall event number
53578

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗